Can Two O Blood Types Make an A?

Under standard genetics, two parents who are both blood type O cannot produce a child with blood type A. Every O-type person carries two copies of the O version of the ABO gene, and since the O version does not produce A or B antigens, there is nothing for either parent to pass along that would create a type A child. Yet families and blood bank workers do occasionally run into exactly this scenario, and the explanation almost always involves a rare genetic variant, a testing error, or a medical condition that makes someone’s blood type appear to be something it is not.

Why the Standard Rule Exists

Your ABO blood type depends on a single gene that comes in three main versions. Two of those versions build sugar molecules (antigens) on the surface of red blood cells: one builds the A antigen, the other builds the B antigen. The third version, O, is essentially a broken copy that does not build either antigen. You inherit one copy from each parent, so a person who types as O carries two non-functional copies. When both parents are type O, every child receives one non-functional copy from each side, and the result is always type O.

That textbook rule holds in the vast majority of cases. But the ABO gene is more complicated than the three-allele model taught in introductory biology. Over 200 variant alleles have been catalogued, and some of them bend the rules in ways that can make the impossible look like it happened.

Weak A Subgroups That Masquerade as O

The most common explanation when two “type O” parents have a “type A” child is that one parent was never truly type O to begin with. Some people carry a version of the A gene that produces so little A antigen on their red blood cells that routine blood typing misses it entirely. These are called weak A subgroups, and there are several of them, ranging from mildly reduced antigen expression to almost none at all.

Standard blood typing works by mixing your red blood cells with reagent antibodies and watching for clumping. If the A antigen is present in normal amounts, the anti-A reagent causes obvious clumping. But when only a trace amount of A antigen sits on the cell surface, the clumping reaction is faint or absent, and the sample gets called type O. Weak agglutination reactions caused by low antigen expression are a recognized source of typing discrepancies in blood banks.¹ A retrospective analysis of typing discrepancies among blood donors found that ABO subgroups accounted for roughly a quarter of all discrepant results, with A subtypes making up the largest share.²

So picture a parent who carries one weak-A allele and one O allele. Their red blood cells display so little A antigen that a routine test calls them type O. They go through life believing they are type O, and then they have a child who inherits the weak-A allele alongside the other parent’s O allele and happens to express just enough A antigen to be detected. The child types as A; both parents type as O; and genetics appears to have been violated. But no rule was broken. The parent was genetically type A all along, just at a level too low for the standard test to catch.

The Cis-AB Phenomenon

In ordinary ABO inheritance, the A and B genes sit on separate chromosomes, so a person who types as AB got their A from one parent and their B from the other. Cis-AB is a rare twist in which a single allele, inherited from one parent, produces an enzyme that builds both A and B antigens. The other chromosome can carry a normal O allele, giving the person what looks like an AB blood type despite having only one “active” ABO allele.³

How does this relate to two type O parents having a type A child? A cis-AB allele arises from a point mutation that changes the sugar-building specificity of the enzyme. In at least one documented case, the mutation swapped a single amino acid in the A-type enzyme, giving it partial B-transferase activity as well.⁴ Other cases involve a structurally abnormal enzyme that can transfer both the A-sugar and the B-sugar.⁵ The cis-AB phenotype has been known to create apparently paradoxical inheritance patterns, such as a child with type O born to a mother who types as AB, because the single cis-AB allele can be passed intact to one child while another child inherits only the parent’s O allele.⁶

Now imagine a parent whose cis-AB allele produces only a weak A component and a very weak B component. Depending on how the enzyme performs, standard serology might label that person as type O if neither antigen is expressed strongly enough to cause visible clumping. Their child could then inherit the cis-AB allele and express the A antigen a bit more robustly, enough to register as type A on a blood test. The genetics look impossible from the outside, but the underlying allele was simply hiding in the parent.

The Bombay Phenotype

This is the most dramatic way two apparent type O parents can have a child who seems like a different blood type. The Bombay phenotype involves a completely separate gene from ABO. Before your red blood cells can display A or B antigens, they first need a foundation molecule called the H antigen. The H antigen is built by an enzyme encoded by the FUT1 gene. If both copies of FUT1 are non-functional, the H antigen never gets made, and without it, neither A nor B can be assembled on the cell surface, regardless of what the person’s ABO gene says.

A person with Bombay phenotype could be genetically type A (carrying an A allele and an O allele) yet have no A or B or H antigens on their red blood cells. On every routine blood test, they look like type O. Mutations that knock out FUT1 have been documented repeatedly, including several novel inactivating mutations found in a Polish cohort.⁷

If a Bombay-phenotype parent who is genetically A/O has a child with a partner who is genetically O/O, and the child inherits a working copy of FUT1 (from either parent, since FUT1 status is inherited independently), that child will display the A antigen normally and type as A. Both parents typed as O, the child types as A, and the family tree seems to defy basic biology. In reality, the Bombay parent always had the A gene but could never express it on their own red blood cells.

How Rare Is the Bombay Phenotype?

Bombay phenotype frequencies vary enormously by geography. In parts of India, estimates run around 1 in 10,000 people, while in most European and East Asian populations it is far rarer, on the order of 1 in several hundred thousand or even 1 in a million. The phenotype is clinically significant for a reason beyond confusing family genetics: people with Bombay phenotype produce powerful anti-H antibodies in addition to anti-A and anti-B. If they receive a transfusion of normal type O blood, the anti-H antibodies attack the donor cells. Case reports have documented severe hemolytic transfusion reactions when Bombay-phenotype patients were given standard type O red blood cells.⁸ In one early study, radiolabeled type O red blood cells infused into a Bombay-phenotype patient had a half-life of just six minutes, with only about two percent of the cells surviving at 24 hours.⁹ The only safe transfusion option for these individuals is blood from another Bombay-phenotype donor.¹⁰

Chimerism and Mixed Cell Populations

Chimerism is a condition in which one person’s body contains cells from two genetically distinct individuals. It can arise naturally, most commonly when fraternal twin embryos exchange blood-forming stem cells early in pregnancy. The result is a person whose blood contains two populations of red blood cells, each with its own ABO type.

A chimeric individual might have one cell line that produces type O red blood cells and another that produces type B, for example. On a blood test, the mixture creates confusing mixed-field reactions that can initially be mistaken for a weak subgroup. One case report described a dispermic chimera whose blood showed mixed-field agglutination with anti-B. Initial molecular analysis found only O alleles, but deeper investigation revealed a hidden B allele present in one of the two cell populations.¹¹ In another case, a healthy woman was found to carry A, B, and O alleles simultaneously, something impossible in a single genome, indicating tetragametic chimerism.¹²

How does this figure into the “two O parents, type A child” scenario? If a parent is chimeric, the majority of their red blood cells could be type O while a small minority are type A. The standard test would call them type O, especially if the type A cell line is a minor component. Their ABO genotype as determined from blood DNA could show O/O, because the DNA sample is dominated by the O cell line. But in their reproductive cells, the A-carrying genome might be fully present, allowing them to pass an A allele to a child.

When Disease Hides a Blood Type

Certain cancers, particularly blood cancers like acute myeloid leukemia, can temporarily suppress the expression of ABO antigens on red blood cells. A person who has always been type A may suddenly type as O during active disease. Case reports have documented patients whose A antigens vanished during the leukemic phase and returned once the disease went into remission.¹³ In one case, a patient’s initial workup pointed to type O, but after chemotherapy began and the cancer responded, his original type A blood group reappeared.¹⁴

This is not a genetic change in the ABO gene itself. The gene is still there. The leukemia disrupts the cellular machinery that assembles the sugar antigens on the cell surface, creating a phenotypic change without a genotypic one. Once the malignant cells are cleared, the remaining healthy blood-forming cells resume normal antigen production. While this would not typically cause a “two O parents, A child” puzzle directly, it illustrates that the blood type written on your medical record is not always a permanent, reliable reflection of your genotype. If a parent’s blood was typed during a period of antigen suppression and later a child’s type does not match the expected pattern, this could contribute to the confusion.

Stem Cell Transplants That Change Blood Type

A blood type can also change outright after certain medical procedures. When someone receives a stem cell transplant from a donor with a different ABO type, their red blood cell population is gradually replaced by donor-derived cells. Over a period of months, the recipient’s serological blood type converts to that of the donor. A study tracking this process over a decade found that the median time to full conversion was roughly three to four months, though it varied depending on the type of ABO mismatch.¹⁵ Among patients with major ABO mismatches, all eventually converted their red cell phenotype to the donor’s blood type.¹⁶

This means a person who was born type A could become type O after a transplant from a type O donor. If they later have children (transplant recipients sometimes retain their original reproductive cells, which are not replaced by the donor), those children could inherit the parent’s original A allele and type as A. The parent’s blood now types as O; the other parent may also be type O; the child comes out type A. From a serological standpoint, the rules were broken. From a genetic standpoint, they never were.

When These Situations Come Up in Real Life

For most people, the question about two O parents producing an A child arises in one of three contexts: a paternity concern, an unexpected blood bank result, or a genetics class exercise that does not quite match the family’s actual types. In the paternity context, blood typing was historically used to exclude accused fathers, since it could prove that a particular man was not the biological father if the child’s type was incompatible with his. But the scenarios described above show how easy it is for blood typing to produce misleading results. A man with a weak A subgroup who types as O could be falsely excluded as the father of a type A child, even though he is the biological father.

Modern paternity testing relies on DNA analysis rather than blood typing, so these rare ABO quirks no longer drive legal outcomes the way they once could. But in clinical settings, the stakes are still high. An unexpected blood type in a newborn can prompt unnecessary conflict between parents. A Bombay-phenotype individual misidentified as type O could receive an incompatible transfusion. Blood bank specialists are trained to investigate typing discrepancies by performing extended serological testing and, when needed, molecular genotyping that reads the ABO gene directly from DNA rather than relying on what the red blood cells display.

Why Blood Type O Is So Common

If the O allele is a “broken” version that fails to produce an antigen, you might wonder why it is the most common allele worldwide rather than a rare defect. One likely contributor is malaria. Research has shown that blood group O provides a degree of protection against severe falciparum malaria compared to groups A, B, and AB, through reduced rosetting, the process by which infected red blood cells clump with uninfected ones and clog small blood vessels.¹⁷ The non-O blood groups have emerged as risk factors for life-threatening malaria because the A and B antigens on red blood cells promote this clumping.¹⁸

In regions with historically heavy malaria pressure, type O is especially prevalent, reaching frequencies above 70 percent in parts of Central and South America. The selective pressure of malaria may have driven the O allele to high frequency over thousands of years, which in turn made “O × O” pairings far more common than they would be in a population with equal allele distribution. The more common these pairings are, the more chances there are for one of the rare exceptions above to surface and baffle the family involved.

Molecular Testing Versus Serological Testing

When a blood type result does not make sense, the gold standard is molecular genotyping, which sequences the ABO gene directly. Standard serological testing asks “what antigens are on the surface of these red blood cells?” Molecular testing asks “what does the DNA actually say?” The two do not always agree, and the gap between them is where most of the surprising scenarios described in this article live. A weak-A parent types as O serologically but as A genotypically. A Bombay-phenotype parent types as O serologically but may carry A or B alleles visible at the DNA level. A chimera shows one genotype in blood DNA and a different one in other tissues.

Molecular genotyping is not routine for every patient, because it is more expensive and time-consuming than mixing a drop of blood with a reagent. But when typing discrepancies arise, or when a patient has received transfusions or transplants that make serological results unreliable, genotyping resolves the mystery. It also settles the family-genetics puzzle with finality: if both parents truly carry O/O genotypes with no hidden variant alleles and no Bombay phenotype, a type A child is not biologically theirs through standard reproduction. If a hidden allele is lurking, the DNA will reveal it.

For anyone facing this situation in real life, the practical step is straightforward. Ask the blood bank or laboratory to investigate the discrepancy with extended testing. In almost every documented case, what looked like an impossible result turned out to have a perfectly logical genetic explanation once someone looked closely enough.